Product Lead, Peptide Therapeutics

Basecamp Research; Boston (MA); Vor Ort; USD 160.000 - 260.000; Vollzeit

Zusammenfassung

Basecamp Research in Boston, USA is seeking a highly capable Product Lead for Peptide Therapeutics. You will own the peptide platform as a commercial product, perform market analysis, define target product profiles, and shape licensing/partnership strategies.

You will bridge model/science teams with business development and drive the roadmap with a data-driven approach. You will collaborate with leadership to translate scientific capabilities into commercially viable offerings, define stage

Aufgaben

• Market and competitive intelligence.
• Build and maintain a rigorous view of the peptide therapeutics landscape by segment, indication and modality, including approved agents, late-stage pipelines, mechanism trends and delivery technologies.
• Track and interpret competitor activity across AI-enabled discovery platforms, peptide-focused biotechs, display and screening technology providers, and internal pharmaceutical capability, translating it into roadmap/pricing implications.
• Maintain a live map of deal structures, comparables and valuation benchmarks in platform licensing and co-development, advising on where our agreements should sit.
• Bring the outside in: run structured voice-of-customer work with pharmaceutical R&D leaders, and turn it into prioritised, written requirements.
• Author and defend target product profiles for internal peptide programmes, specifying load-bearing properties, desirable traits and evidence.
• Translate partner-supplied target product profiles into feasible research plans with scientific leadership, including honest assessments of platform capabilities today.
• Define stage gates and go/no-go criteria for peptide programmes, and make recommendations on when to stop.
• Decide which platform capabilities become licensable products and define sequencing to balance near-term revenue with durable differentiation.
• Own the peptide product roadmap end to end, align with model/data/science teams and manage scope.
• Define packaging and commercial models for offerings, including access arrangements, co-development structures and asset-level licensing.
• Specify data needs from partners to improve and turn collaboration offers into precise written requests.
• Build the peptide narrative and materials: capability maps, benchmark summaries, validation packages and competitive comparisons for senior scientists.
• Set and enforce the standard for external claims, ensuring accuracy and caveats across documents.
• Support business development through partner meetings, scientific exchanges, conferences and diligence processes.

Jobbeschreibung

About us

Basecamp Research is building frontier AI for therapeutic design. We believe the future of medicine lies in reprogramming the body to repair itself, and we design the models and the medicines to teach it how.

Our EDEN models are trained on BaseData, the world's largest proprietary genomic dataset, with over 10B genes collected through partnerships in more than 30 countries across all seven continents. This gives our AI models access to genetic diversity that doesn't exist in public databases, and enables EDEN to design cell and gene therapies, enzymes, and peptides directly from information about a disease.

In September 2026 we closed an oversubscribed $140M Series C led by S32, with participation from NVIDIA, Anthropic's Anthology Fund, Catalio, European Tech Collective, Firebrand River Capital, King Philanthropies, NATO Innovation Fund, NVentures (NVIDIA's venture arm), Redalpine, Rockefeller Foundation, Singular, Sovereign AI and True Ventures.

We have offices and labs in London and Boston, we partner with biopharma companies and academic institutions worldwide, and our work has been recognised by Fast Company's Top 10 Most Innovative Companies in Biotech, the FT-backed Sifted AI100 list of Europe's leading AI startups as well as Barclays Eagle Labs Ones to watch, AI100.

At Basecamp Research, we pride ourselves on being a lean collaborative and global team with extremely specialist and unique skills. Our biologists, engineers, ML scientists and field explorers are united by a sense of adventure and the belief that AI, biology and data, will result in new medicines for patients who have few options today.

The Role

We are seeking a highly capable and proactive Product Lead, Peptide Therapeutics to join our Boston, USA team, initially reporting into our Chief Technology Officer. This role owns the peptide platform as a commercial product: the market analysis behind it, the target product profiles it is judged against, the decisions about what we build and license first, and the positioning that partners hear. You will sit between our model and science teams and our business development function, and you will be accountable for the peptide portfolio having a defined buyer, a defensible claim and a credible price.

Key Responsibilities

• Market and competitive intelligence
• Build and maintain a rigorous view of the peptide therapeutics landscape by segment, indication and modality, including approved agents, late-stage pipelines, mechanism trends and delivery technologies.
• Track and interpret competitor activity across AI-enabled discovery platforms, peptide-focused biotechs, display and screening technology providers, and internal pharmaceutical capability, and translate it into implications for our roadmap and pricing.
• Maintain a live map of deal structures, comparables and valuation benchmarks in platform licensing and co-development, and advise on where our agreements should sit.
• Bring the outside in: run structured voice-of-customer work with pharmaceutical R&D leaders, and turn it into prioritised, written requirements rather than anecdotes.

Target product profiles and programme definition

• Author and defend target product profiles for internal peptide programmes, specifying which properties are load-bearing, which are desirable, and what evidence would falsify the case.
• Translate partner-supplied target product profiles into feasible research plans in collaboration with scientific leadership, including honest assessments of what our platform can and cannot address today.
• Define stage gates and go or no-go criteria for peptide programmes, and make the recommendation when a programme should stop.

Productisation and roadmap

• Decide, on evidence, which platform capabilities become licensable products and in what sequence, balancing near-term revenue against durable differentiation.
• Own the peptide product roadmap end to end, agreeing priorities with model, data and science teams and holding the line on scope.
• Define packaging and commercial models for each offering, including access arrangements, bespoke model fine-tuning on partner data, co-development structures and asset-level licensing.
• Specify the data we need from partners in order to improve, and turn broad offers of collaboration into precise, written requests.

Positioning, evidence and partner engagement

• Build the peptide narrative and the materials behind it: capability maps, benchmark summaries, validation packages and competitive comparisons that hold up under scrutiny from senior pharmaceutical scientists.
• Set and enforce the standard for external claims, ensuring that what we say about validation, benchmarks and limitations is accurate, consistent across documents, and appropriately caveated.
• Support business development through partner meetings, scientific exchanges, conferences and diligence processes